Citigroup
AKAO

Citigroup’s Achaogen Inc AKAO Stock Holding History

Citigroup’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,400
Closed -$1K – 7959
2019
Q1 		$1K Buy
2,400
+1,700
+243% +$1.78K ﹤0.01% 7620
2018
Q4 		$1K Sell
700
-23,700
-97% -$63.3K ﹤0.01% 7629
2018
Q3 		$97K Buy
+24,400
New +$147K ﹤0.01% 5947

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Citigroup's AKAO Position: Q2 2019 in Review

Citigroup sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 17,540 shares — an estimated $8K sold.

Citigroup first reported a position in AKAO in Q2 2014 and held it in 16 quarters. The position peaked at $1.38M in Q2 2017. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.

  • Citigroup reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
  • Citigroup sold 17,540 Achaogen Inc shares in Q2 2019, an estimated $8K.
  • Citigroup first reported a position in Achaogen Inc in Q2 2014 and held it in 16 quarters.
  • Citigroup's Achaogen Inc position peaked at $1.38M in Q2 2017.
  • 8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.

Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.